SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-09-000704
Filing Date
2009-05-15
Accepted
2009-05-15 16:25:19
Documents
7
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K cardiome6k.htm 6-K 23402
2 NEWS RELEASE DATED MAY 15, 2009 ex991.htm EX-99.1 19346
3 FIRST QUARTER REPORT FOR THE PERIOD ENDED MARCH 31, 2009 ex992.htm EX-99.2 581761
4 CERTIFICATE OF FILING - CEO ex993.htm EX-99.3 18477
5 CERTIFICATE OF FILING - CFO ex994.htm EX-99.4 18480
6 RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES ex995.htm EX-99.5 190419
7 CARDIOME PHARMA LOGO cardiome.jpg GRAPHIC 8025
  Complete submission text file 0001279569-09-000704.txt   864625
Mailing Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3
Business Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 09833491
SIC: 2834 Pharmaceutical Preparations